About us




We believe in openness, in scholarly publishing and research communication.

Announcements

In March, Hindawi’s Head of Research Integrity Matt Hodgkinson was elected to the Council of the Committee on Publication Ethics. He looks at how approaches to research integrity have evolved over the years he’s focused on ethics.

A cross publisher collaboration aims to ensure research related to COVID-19 is reviewed and published as quickly as possible. An Open Letter of...

Our latest and upcoming partnerships, with Writefull, Morressier, CCDC...

We remain open and committed to sharing findings related to COVID-19.

Our mission

By placing the research community at the heart of everything we do, we strive for a future where researchers are motivated to work together, empowered with the tools and services they need to do so, and freed from any barriers that stand in their way. We aim to maximize the impact of scientific research through openness and global collaboration as we truly believe that science works best when research is open.

Our mission

For publishers

For publishers
To assist publishers and societies in embracing the advantages offered by an open access publishing model, we have created Phenom - a simple, intuitive, cost-effective publishing solution that supports all workflows; from submission and peer review through to production and publication. Partner with us

For authors

For authors
With the researcher at the heart of the publishing experience, we have created a diverse portfolio of peer-reviewed, open access journals across a wide range of scientific and medical disciplines. Choose the journal that fits your niche.Publish with us

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.